Bone Marrow TransplantationHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation, AutologousBone Marrow CellsStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem CellsBone and BonesWhole-Body IrradiationGraft SurvivalStem CellsTransplantation ChimeraCord Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationBusulfanTissue DonorsCombined Modality TherapyLeukemiaCyclophosphamideLiver TransplantationTreatment OutcomeGranulocyte Colony-Stimulating FactorMelphalanHistocompatibility TestingAnemia, AplasticAntigens, CD34RecurrenceHistocompatibilityRemission InductionBone Marrow DiseasesMultiple MyelomaHematopoiesisBone Marrow PurgingLeukapheresisTransplantation, IsogeneicAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteKidney TransplantationMyeloablative AgonistsTime FactorsRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesHematologic DiseasesBlood Component RemovalGraft vs Leukemia EffectBone Marrow ExaminationSurvival RateEtoposideMice, Inbred C57BLCell DifferentiationBone RemodelingMesenchymal Stem Cell TransplantationLymphocyte DepletionTransplantation ImmunologyInfectionHepatic Veno-Occlusive DiseaseImmunosuppressionBone Marrow NeoplasmsHLA AntigensCytarabineCell TransplantationGraft RejectionAntineoplastic Agents, AlkylatingAcute DiseaseColony-Forming Units AssayCarmustineHodgkin DiseaseSalvage TherapyFollow-Up StudiesHeart TransplantationCytomegalovirus InfectionsBlood CellsVidarabineT-LymphocytesThiotepaRadiation ChimeraLymphomaCyclosporineLeukemia, MyeloidFatal OutcomeLymphocyte TransfusionLung TransplantationGraft vs Tumor EffectFlow CytometryVincristineCells, CulturedNuclear FamilyBone DensityLeukocyte Count